All News #Library
Biotech
NRG Therapeutics Initiates Phase 1 Trial For NRG5051 In ALS/MND
08 Jan 2026 //
PHARMIWEB
NRG Secures £50M Series B Funding for Parkinson`s Research
08 Sep 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support